247 related articles for article (PubMed ID: 15858181)
21. Hemochromatosis, HFE C282Y homozygosity, and polycystic ovary syndrome: report of two cases and possible effects of androgens and hepcidin.
Barton JC; Barton JC
Acta Haematol; 2011; 126(3):138-40. PubMed ID: 21701160
[No Abstract] [Full Text] [Related]
22. Molecular insights into the pathogenesis of hereditary haemochromatosis.
Pietrangelo A
Gut; 2006 Apr; 55(4):564-8. PubMed ID: 16531535
[No Abstract] [Full Text] [Related]
23. Iron disorders of genetic origin: a changing world.
Brissot P; Bardou-Jacquet E; Jouanolle AM; Loréal O
Trends Mol Med; 2011 Dec; 17(12):707-13. PubMed ID: 21862411
[TBL] [Abstract][Full Text] [Related]
24. Non-HFE hemochromatosis.
Pietrangelo A
Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
[TBL] [Abstract][Full Text] [Related]
25. [Hypersiderosis and dissiderosis in the context of data on hemochromatosis microelementosis].
Smirnov OA
Arkh Patol; 2008; 70(3):3-8. PubMed ID: 18727423
[TBL] [Abstract][Full Text] [Related]
26. [Primary hemochromatosis as a disease provoked by hepcidin deficiency?].
Iwai K; Hishikawa K
Nihon Rinsho; 2006 Sep; Suppl 3():611-5. PubMed ID: 17022620
[No Abstract] [Full Text] [Related]
27. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women.
Roe MA; Spinks C; Heath AL; Harvey LJ; Foxall R; Wimperis J; Wolf C; Fairweather-Tait SJ
Br J Nutr; 2007 Mar; 97(3):544-9. PubMed ID: 17313717
[TBL] [Abstract][Full Text] [Related]
28. Protective role of calreticulin in HFE hemochromatosis.
Pinto JP; Ramos P; de Almeida SF; Oliveira S; Breda L; Michalak M; Porto G; Rivella S; de Sousa M
Free Radic Biol Med; 2008 Jan; 44(1):99-108. PubMed ID: 18045552
[TBL] [Abstract][Full Text] [Related]
29. Molecular basis of primary iron overload in India and the role of serum-derived factors in hepcidin regulation.
Athiyarath R; Srivastava A; Edison ES
Ann Hematol; 2013 Jun; 92(6):843-4. PubMed ID: 23154866
[No Abstract] [Full Text] [Related]
30. Iron genes, dysmetabolism and fibrosis in chronic hepatitis C.
Valenti L; Dongiovanni P; Fargion S; Fracanzani AL
J Hepatol; 2008 Mar; 48(3):513-4; author reply 514-5. PubMed ID: 18194822
[No Abstract] [Full Text] [Related]
31. [Hereditary haemochromatosis: novel genes, novel diseases and hepcidin].
Bergmans JP; Kemna EH; Janssen MC; Jacobs EM; Stalenhoef AF; Marx JJ; Swinkels DW
Ned Tijdschr Geneeskd; 2007 May; 151(20):1121-7. PubMed ID: 17557668
[TBL] [Abstract][Full Text] [Related]
32. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
[TBL] [Abstract][Full Text] [Related]
33. Novel genes, proteins, and inherited disorders of iron overload: iron metabolism is less boring than thought.
Cazzola M
Haematologica; 2002 Feb; 87(2):115-6. PubMed ID: 11836159
[No Abstract] [Full Text] [Related]
34. Hemochromatosis and iron overload: from bench to clinic.
Barton JC
Am J Med Sci; 2013 Nov; 346(5):403-12. PubMed ID: 24157962
[No Abstract] [Full Text] [Related]
35. Hfe acts in hepatocytes to prevent hemochromatosis.
Vujić Spasić M; Kiss J; Herrmann T; Galy B; Martinache S; Stolte J; Gröne HJ; Stremmel W; Hentze MW; Muckenthaler MU
Cell Metab; 2008 Feb; 7(2):173-8. PubMed ID: 18249176
[TBL] [Abstract][Full Text] [Related]
36. [Hepcidin, a new protein of body iron homeostasis].
del Castillo Rueda A; de Portugal Alvarez J
An Med Interna; 2003 Dec; 20(12):605-6. PubMed ID: 14697078
[No Abstract] [Full Text] [Related]
37. Hereditary iron overload: update on pathophysiology, diagnosis, and treatment.
Franchini M
Am J Hematol; 2006 Mar; 81(3):202-9. PubMed ID: 16493621
[TBL] [Abstract][Full Text] [Related]
38. An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice.
Roy CN; Custodio AO; de Graaf J; Schneider S; Akpan I; Montross LK; Sanchez M; Gaudino A; Hentze MW; Andrews NC; Muckenthaler MU
Nat Genet; 2004 May; 36(5):481-5. PubMed ID: 15098034
[TBL] [Abstract][Full Text] [Related]
39. Soluble transferrin receptor and iron homeostasis.
Worwood M
Haematologica; 2005 Jan; 90(1):2. PubMed ID: 15644300
[No Abstract] [Full Text] [Related]
40. Defective release of Hepcidin not defective synthesis is the primary pathogenic mechanism in HFE-Haemochromatosis.
Arnold J; Sangwaiya A; Bhatkal B; Arnold A
Med Hypotheses; 2008; 70(6):1197-200. PubMed ID: 18054440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
